Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...
10/10/2025 Brief amici curiae of 18 Members of the Committee on the Judiciary of the U.S. House of Representatives filed. VIDED. 10/24/2025 Brief amici curiae of Tennessee, et al. filed. VIDED.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results